Skip Navigation

Strengthen the Evidence for Maternal and Child Health Programs

Sign up for MCHalert eNewsletter

Search Results: MCH Organizations

This list of organizations is drawn from the MCH Organizations Database. Contact information is the most recent known to the MCH Digital Library.

Displaying records 1 through 2 (2 total).

Celiac Sprue Association/United States of America (CSA/USA)

Annotation: The Celiac Sprue Association/United States of America (CSA/USA) provides information and referral services for people with celiac sprue (gluten-sensitive enteropathy and dermatitis herpetiformis) and for parents of children with celiac disease. Publications include a quarterly newsletter, Lifeline, a handbook and a series of brochures on gluten-free commercial foods, gluten-free diet, and related topics. The association, which also sponsors conferences and workshops, has six U.S. regions, 91 chapters, and over 50 active resource units.

Keywords: Celiac disease, Dermatitis herpetiformis, Diet therapy, Gastrointestinal diseases, Gluten intolerance, Gluten sensitive enteropathy

Gluten Intolerance Group® (GIG®)

Annotation: The Gluten Intolerance Group® (GIG®) offers assistance, counseling, and referrals to people with celiac sprue and/or dermatitis herpetiformis, their families, consumers, and health care professionals. Publications include diet instruction, gluten-free bread recipes, an introductory brochure, a resource guide, research reports, and the quarterly GIG® Newsletter. Materials are available in Braille and Spanish. A catalog of audiovisual materials is available. GIG® also sponsors conferences, training seminars, and workshops. GIG® was formerly called the Gluten Intolerance Group of North America.

Keywords: Celiac disease, Dermatitis herpetiformis, Gluten intolerance, Self help clearinghouses
   

This project is supported by the Health Resources and Services Administration (HRSA) of the U.S. Department of Health and Human Services (HHS) under grant number U02MC31613, MCH Advanced Education Policy, $3.5 M. This information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS or the U.S. Government.